Author:
Mashru Puneet,Mukhtyar Chetan
Reference35 articles.
1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11
2. Guillevin L, Mukhtyar C, Pagnoux C, Yates M (2018) Conventional and biological immunosuppressants in vasculitis. Best Pract Res Clin Rheumatol 32(1):94–111
3. Mukhtyar C, Hellmich B, Jayne D, Flossmann O, Luqmani R (2006) Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Clin Exp Rheumatol 24(6):S93
4. Mukhtyar CB, Flossmann O, Luqmani RA (2006) Clinical and biological assessment in systemic necrotizing vasculitides. Clin Exp Rheumatol 24(2 Suppl 41):S92–S99
5. Walsh M, Mukhtyar C, Mahr A, Herlyn K, Luqmani R, Merkel PA et al (2011) Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res (Hoboken) 63(7):1055–1061